The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer

BACKGROUND: Oxaliplatin, irinotecan, 5-fluorouracil, and l-leucovorin (FOLFIRINOX) has become one of the first-line treatment options for advanced pancreatic cancer (PC). However, the relatively high rate of grade 3 or 4 adverse events associated with the standard dosage of FOLFIRINOX limits its wid...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhi-Qiang, Zhang, Fei, Deng, Ting, Zhang, Le, Feng, Fen, Wang, Feng-Hua, Wang, Wei, Wang, De-Shen, Luo, Hui-Yan, Xu, Rui-Hua, Ba, Yi, Li, Yu-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507030/
https://www.ncbi.nlm.nih.gov/pubmed/31068222
http://dx.doi.org/10.1186/s40880-019-0367-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507030/
https://www.ncbi.nlm.nih.gov/pubmed/31068222
http://dx.doi.org/10.1186/s40880-019-0367-7

Ejemplares similares